ArisGlobal Unveils NavaX Translation to Revolutionize Global Pharmacovigilance with AI Integration
In a groundbreaking move to enhance pharmacovigilance, ArisGlobal has announced the launch of NavaX Translation, designed to streamline the translation process within its LifeSphere Safety platform. With this innovation, the company aims to significantly improve the efficiency of handling multilingual safety reports for pharmaceutical companies worldwide. As the demand for swift and precise safety report processing grows, the integration of certified translation services into existing workflows is set to transform the industry by removing the need for manual translation processes.
The current operational landscape in global drug safety monitoring often sees teams dealing with a surge of safety reports submitted in various languages. The traditional procedure involves exporting documents for translation, which is a labor-intensive task that can lead to delays and compliance issues. With NavaX Translation, this problematic process can now be bypassed. This new feature leverages intelligent language detection to automatically identify safety forms not in English and routes them for certified translation to TransPerfect, a strategic partner specializing in Life Sciences translation.
Deputy Jason Bryant, representing ArisGlobal, highlighted the importance of this innovation, stating, "NavaX Translation embodies our commitment to integrating intelligent automation directly into core workflows, ensuring high-quality translation that meets the rigorous standards of global pharmacovigilance." The technology employs AI-driven models tailored for the pharmaceutical sector, facilitating faster turnaround times for translations—bringing it down from hours to mere minutes.
One of the key advantages of NavaX Translation lies in its seamless integration with LifeSphere Safety through an API. This means that the need for manual export and import of translated documents has been completely erased. This enhances not just the speed but also the accuracy of the reporting necessary for compliance with global regulatory standards. As the system can now support a vast number of cases across different markets, scalability is no longer an issue for companies navigating this complex environment.
Beyond just efficiency, NavaX Translation guarantees that translation results meet all necessary compliance requirements. As reported, the platform is currently managing over 1 million safety cases, a figure expected to grow to 2.5 million by mid-2026. Performance metrics reveal that the use of NavaX is leading to a data accuracy rate exceeding 95% and efficiency gains above 30%, showcasing its significant return on investment.
The implementation of this advanced system is part of a broader strategy that reflects ArisGlobal's position as a leader in technological innovation within the life sciences. Their commitment to offering solutions that not only meet industry challenges but also provide pathways for global expansion is evident in this recent advancement. Furthermore, as Kevin Obarski, Growth Director at TransPerfect, notes, partnering with ArisGlobal means integrating validated translation within an intelligent safety platform, empowering life sciences organizations to operate globally with compliance and confidence.
Scheduled for release to LifeSphere Safety clients in July 2026, NavaX Translation demonstrates ArisGlobal's proactive approach in delivering solutions that prioritize speed, accuracy, and regulatory adherence—which are crucial for pharmaceutical companies in today's fast-paced market. This innovation not only signifies a leap in capabilities for safety reporting but also redefines how companies can harness technology to enhance patient safety initiatives across various languages and jurisdictions. For more details on NavaX Translation, visit NavaX Translation | ArisGlobal.
ArisGlobal, headquartered in the United States, is synonymous with pioneering technology in life sciences, championing new methodologies that streamline the path from research to market. By making these advances, they continue to set the standards for how the life sciences can leverage AI for humane outcomes.
TransPerfect Life Sciences, renowned for supporting the global development of life-saving medicines and devices, partners with organizations to facilitate top-notch pharmacovigilance solutions. Together, ArisGlobal and TransPerfect are at the forefront of transforming the landscape of safety reporting in the pharmacovigilance sector, addressing the increasing complexity and volume of safety data being generated.
This transformative product clearly represents a necessary evolution that reflects the future trajectory of pharmacovigilance, grounded in innovation, compliance, and industry collaboration.
The current operational landscape in global drug safety monitoring often sees teams dealing with a surge of safety reports submitted in various languages. The traditional procedure involves exporting documents for translation, which is a labor-intensive task that can lead to delays and compliance issues. With NavaX Translation, this problematic process can now be bypassed. This new feature leverages intelligent language detection to automatically identify safety forms not in English and routes them for certified translation to TransPerfect, a strategic partner specializing in Life Sciences translation.
Deputy Jason Bryant, representing ArisGlobal, highlighted the importance of this innovation, stating, "NavaX Translation embodies our commitment to integrating intelligent automation directly into core workflows, ensuring high-quality translation that meets the rigorous standards of global pharmacovigilance." The technology employs AI-driven models tailored for the pharmaceutical sector, facilitating faster turnaround times for translations—bringing it down from hours to mere minutes.
One of the key advantages of NavaX Translation lies in its seamless integration with LifeSphere Safety through an API. This means that the need for manual export and import of translated documents has been completely erased. This enhances not just the speed but also the accuracy of the reporting necessary for compliance with global regulatory standards. As the system can now support a vast number of cases across different markets, scalability is no longer an issue for companies navigating this complex environment.
Beyond just efficiency, NavaX Translation guarantees that translation results meet all necessary compliance requirements. As reported, the platform is currently managing over 1 million safety cases, a figure expected to grow to 2.5 million by mid-2026. Performance metrics reveal that the use of NavaX is leading to a data accuracy rate exceeding 95% and efficiency gains above 30%, showcasing its significant return on investment.
The implementation of this advanced system is part of a broader strategy that reflects ArisGlobal's position as a leader in technological innovation within the life sciences. Their commitment to offering solutions that not only meet industry challenges but also provide pathways for global expansion is evident in this recent advancement. Furthermore, as Kevin Obarski, Growth Director at TransPerfect, notes, partnering with ArisGlobal means integrating validated translation within an intelligent safety platform, empowering life sciences organizations to operate globally with compliance and confidence.
Scheduled for release to LifeSphere Safety clients in July 2026, NavaX Translation demonstrates ArisGlobal's proactive approach in delivering solutions that prioritize speed, accuracy, and regulatory adherence—which are crucial for pharmaceutical companies in today's fast-paced market. This innovation not only signifies a leap in capabilities for safety reporting but also redefines how companies can harness technology to enhance patient safety initiatives across various languages and jurisdictions. For more details on NavaX Translation, visit NavaX Translation | ArisGlobal.
ArisGlobal, headquartered in the United States, is synonymous with pioneering technology in life sciences, championing new methodologies that streamline the path from research to market. By making these advances, they continue to set the standards for how the life sciences can leverage AI for humane outcomes.
TransPerfect Life Sciences, renowned for supporting the global development of life-saving medicines and devices, partners with organizations to facilitate top-notch pharmacovigilance solutions. Together, ArisGlobal and TransPerfect are at the forefront of transforming the landscape of safety reporting in the pharmacovigilance sector, addressing the increasing complexity and volume of safety data being generated.
This transformative product clearly represents a necessary evolution that reflects the future trajectory of pharmacovigilance, grounded in innovation, compliance, and industry collaboration.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.